Amy King, JD

* Currently +70% growth with CMI in Dallas market

• Currently leads the Nation in Eliquis; continued +2% growth YOY
• Leads Therapeutic Area Specialists in Dallas Metro area and East Texas, 3 Institutional TASs and 6 Retail TBMs
• Led two TASs to Winner Circle performance 2022, 2024
• January – June 2024: #2 in the Region, #7 in the Nation as a district
• CTAS Winner’s Circle 2024
• Top IS Specialty TAS in Nation
• Camzyos DBM Region lead 2022-2024
• IC Region lead 2022 – 2024
• Successfully launched rare disease product
• Championed initiatives to increase patient access in hospital settings and establish real-world data pathways for patients
• Led a training initiative for Region and Nation on clinical confidence in 2023
• Led Heartland Region launch product clinical knowledge and strategy
• Consistent top performer and advisor on brand initiatives
• Completed Eliquis Consumer Marketing Tour of Duty
• Cultivated thought leaders across Dallas and East Texas, enhancing regional influence and knowledge sharing
• Developed Patient Discussion Guide to be used in the field
• Conducted market research with HCPs and patients to inform strategic direction
• Developed HCP Discussion guide and training video launching 2025

• Promoted to Manager, Field Operations May 2021
• Promoted to Executive TBM January 2020
• Acting AMFO for Heartland Region 2018 – 2021
• Executive Hybrid TBM, East Texas October 2015 – May 2021
• Ranked as top performer in 2016 and 2017, earning Winner’s Circle recognition.
• Secured top overall ratings in annual TBM evaluations.
• Acting DBM for Arkansas/Louisiana District August 2020– January 2021
• Served as District Sales Trainer for Dallas District from 2016 to 2020.
• Editor and Publisher of Field Link 2018 – 2019, Cardiovascular Business Unit
• Received recognition from Rita Faucett (VP Sales) for delivering outstanding presentation at National DBM meeting.
• Partnered with Regional DBMs to interview top talent
• Partnered with Houston DBM and RBD to develop mentoring program with several TBMs

• Promoted Xarelto and Adempas to Cardiologists and Pulmonologists, enhancing product awareness and driving sales growth
• Achieved Top 5% ranking for 4 consecutive quarters, demonstrating consistent high performance
• Earned Living L.I.F.E Award in 2014 for exceptional sales performance and commitment to team goals
• Effectively partnered with co-promoters on two products
• Field Sales Trainer 2013 – 2015
• Completed Train the Trainer class at Bayer Corporate in 2014

• Developed targeted marketing strategies to enhance Xarelto visibility among healthcare providers
• Collaborated with Janssen to strategically target and manage large territory in East TX
• Educated healthcare professionals on product features and benefits.
• Developed tailored sales strategies for diverse accounts.
• Collaborated with cross-functional teams to enhance product positioning.

• Six years of experience with Eli Lilly and Company, spanning across different divisions
• Finished top 2%, Rank of 10th nationally in 2012
• Presented for President’s Council for selling year 2012
• Promoted to Senior Sales Representative 2012
• Product Champion for consecutive years 2009 - 2012
• District Leader for Cialis 2011
• Chosen as a MidWest Area Player for Cymbalta 2012
• Peer to Peer Implementation Specialist for District
• Championed business ownership initiatives 2010-2011, enhancing team engagement and accountability
• National Pilot team for new selling model 2009
• Led area meeting as co-developer for training sales representatives on new selling model October 2009, fostering alignment and effectiveness
• Earned MVP award for exceptional contributions at the area meeting in October 2009.
• Received district MVP award for exemplary achievements in sales during 2009.
• Developed speaker training program for Forteo 2008-2009, improving product knowledge among representatives